The Bridging study of RNTA06, which is indicated for the treatment of chronic angina, is completed and unblended,
2019.6.26
The Bridging study of RNTA06, which is indicated for the treatment of chronic angina, is completed and unblended,
...
TSH Biopharm acquires the commercialization right of all CellMax Life liquid-biopsy diagnosis products
2019.2.13
TSH Biopharm acquires the commercialization right of all CellMax Life liquid-biopsy diagnosis products
...
